Evidence-based prescribing: combining network meta-analysis with multicriteria decision analysis to choose among multiple drugs

Affiliations

• ¹ From the LSE Health, Department of Social Policy, London School of Economics and Political Science, London, United Kingdom (H.N.); Drug Policy Research Group, Department of Population Medicine, Harvard Medical School and Harvard Pilgrim Health Care Institute, Boston, MA (H.N.); Department of Epidemiology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands (G.v.V.); School of Social and Community Medicine (J.P.T.H.) and School of Social and Community Medicine (A.E.A.), University of Bristol, Bristol, United Kingdom; Centre for Reviews and Dissemination, University of York, York, United Kingdom (J.P.T.H.); and Program on Comparative Effectiveness Research Methods and Infrastructure, Patient-Centered Outcomes Research Institute, Washington, DC (R.F.). [email protected].
• ² From the LSE Health, Department of Social Policy, London School of Economics and Political Science, London, United Kingdom (H.N.); Drug Policy Research Group, Department of Population Medicine, Harvard Medical School and Harvard Pilgrim Health Care Institute, Boston, MA (H.N.); Department of Epidemiology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands (G.v.V.); School of Social and Community Medicine (J.P.T.H.) and School of Social and Community Medicine (A.E.A.), University of Bristol, Bristol, United Kingdom; Centre for Reviews and Dissemination, University of York, York, United Kingdom (J.P.T.H.); and Program on Comparative Effectiveness Research Methods and Infrastructure, Patient-Centered Outcomes Research Institute, Washington, DC (R.F.).